Laterza, Lucrezia
 Distribuzione geografica
Continente #
EU - Europa 2.165
NA - Nord America 1.739
AS - Asia 974
SA - Sud America 248
AF - Africa 21
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.162
Nazione #
US - Stati Uniti d'America 1.699
DE - Germania 553
IT - Italia 427
SG - Singapore 369
SE - Svezia 326
CN - Cina 315
BR - Brasile 224
FR - Francia 177
PL - Polonia 177
UA - Ucraina 104
IE - Irlanda 91
GB - Regno Unito 84
ID - Indonesia 74
FI - Finlandia 72
IN - India 55
KR - Corea 39
RU - Federazione Russa 39
NL - Olanda 27
BE - Belgio 21
CA - Canada 20
TR - Turchia 18
HK - Hong Kong 15
AT - Austria 13
IQ - Iraq 13
IR - Iran 13
AU - Australia 11
CZ - Repubblica Ceca 11
MX - Messico 11
JP - Giappone 10
VN - Vietnam 9
AR - Argentina 8
BD - Bangladesh 7
ES - Italia 7
RO - Romania 7
CI - Costa d'Avorio 6
PH - Filippine 6
HU - Ungheria 5
PK - Pakistan 5
ZA - Sudafrica 5
CH - Svizzera 4
IL - Israele 4
LT - Lituania 4
SA - Arabia Saudita 4
VE - Venezuela 4
BO - Bolivia 3
EG - Egitto 3
EU - Europa 3
JM - Giamaica 3
LV - Lettonia 3
MA - Marocco 3
PT - Portogallo 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CO - Colombia 2
EC - Ecuador 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
PA - Panama 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.162
Città #
Chandler 336
Singapore 264
Ashburn 161
Warsaw 150
Dublin 88
Rome 87
New York 74
Jakarta 70
Ann Arbor 68
Jacksonville 66
San Mateo 62
Milan 59
Cattolica 54
The Dalles 50
Frankfurt am Main 46
Seoul 39
Wilmington 39
Hefei 38
Munich 38
Nanjing 36
Boston 33
Helsinki 32
Los Angeles 30
Woodbridge 30
Moscow 28
Beijing 27
Boardman 27
Dearborn 27
Fairfield 25
Marseille 25
North Bergen 24
Nürnberg 24
Lawrence 22
Hyderabad 21
São Paulo 21
Nuremberg 20
Brussels 18
Houston 18
Princeton 18
Seattle 18
Düsseldorf 15
Kraków 15
London 14
Redwood City 14
Bremen 13
Hong Kong 13
Lancaster 13
Izmir 12
Turku 12
Monza 11
Mountain View 11
Shenyang 11
Fremont 10
Hangzhou 10
Lauterbourg 10
Naples 10
Roubaix 10
Tianjin 10
Baghdad 9
Hebei 9
Nanchang 9
Shanghai 9
Kish 8
Paris 8
Portsmouth 8
Santa Clara 8
Toronto 8
Wroclaw 8
Belo Horizonte 7
Cambridge 7
San Francisco 7
Abidjan 6
Amsterdam 6
Andover 6
Bexley 6
Changsha 6
Council Bluffs 6
Guangzhou 6
Jiaxing 6
Lappeenranta 6
Melbourne 6
Newark 6
Redmond 6
San Diego 6
Vienna 6
Washington 6
Zhengzhou 6
Brooklyn 5
Falkenstein 5
Groningen 5
Kunming 5
Mexico City 5
Ottawa 5
Pune 5
Arezzo 4
Augusta 4
Brno 4
Busto Arsizio 4
Cagayan de Oro 4
Campinas 4
Totale 2.787
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 305
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 165
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 147
Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet? 141
13C-octanoic acid breath test to study gastric emptying time 135
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 132
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 127
Erratum to: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (Scientific Reports, (2018), 8, 1, (12624), 10.1038/s41598-018-29311-y) 111
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 109
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 108
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 105
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 102
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 102
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 101
Origin of celiac disease: How old are predisposing haplotypes? 99
Gastrointestinal motility disorder assessment in systemic sclerosis 97
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 97
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 96
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study 95
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 92
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 87
Pancreatic function assessment 85
Gastrointestinal motility disorder assessment in systemic sclerosis 83
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 81
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 79
Diet-Induced Alterations in Gut Microbiota Composition and Function 78
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 73
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 71
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 70
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 70
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 69
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 69
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 68
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 66
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE 62
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 62
Radiomics could predict surgery at 10 years in Crohn's disease 59
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 59
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 58
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 55
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 55
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 54
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 53
Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence 53
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 51
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 48
Bariatric procedures and microbiota: patient selection and outcome prediction 47
Clinical value of alarm features for colorectal cancer: A meta-analysis 46
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 45
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together 44
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 44
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 44
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 43
Clinical value of alarm features for colorectal cancer: A meta-analysis 40
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 38
Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases 36
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 35
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature 35
Risk factors for gastric cancer: is it time to discard PPIs? 35
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 33
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature 33
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 33
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons 32
How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model 31
PET in inflammatory bowel diseases: a new FAPI era? 30
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 30
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 30
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 27
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 27
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 25
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis 25
Addressing Nutritional Knowledge Gaps in Inflammatory Bowel Disease: A Scoping Review 24
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 23
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 23
Review Article: Green Management of IBD—New Paradigms for an Eco-Friendly Approach 22
Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer 20
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 18
Clinical, Radiological, and Surgical Risk Factors for Endoscopic Anastomotic Recurrence Following Surgery in Crohn's Disease 15
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 14
Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: A propensity score-matched study 14
Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data 10
Clinical Trial IBD Unit: The Role of the Study Nurse in Conduction of Trials and Patients' Care 9
Totale 5.264
Categoria #
all - tutte 26.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 0 22
2020/2021281 14 30 6 26 39 17 32 6 30 16 57 8
2021/2022364 15 25 5 14 22 16 6 71 14 51 56 69
2022/2023930 108 126 79 136 58 101 55 79 93 36 40 19
2023/2024728 25 125 51 46 42 108 50 19 46 34 82 100
2024/20251.734 27 42 147 52 139 63 116 78 181 238 422 229
Totale 5.264